Amitabh Dube has been appointed President of OPPI for a two-year term effective September 10, 2026. He will lead OPPI’s efforts to advance innovation, healthcare access and collaboration across India’s pharmaceutical sector.
Nitin Prabhakar, Managing Director (MD), Anton Paar India, puts stronger emphasis on how the company enables Indian pharmaceutical manufacturers to produce globally accepted, high-quality products rather than promot...
Precision medicine is redefining healthcare by enabling faster, more accurate and personalised treatment strategies. Harkaran Dhingra, CEO, DSS Takara Bio India, shares with Pharma Industrial India, insights on Indi...
As India’s pharmaceutical sector continues to attract global investment, the role of pharmacy education has never been more important. Dr. Abha Doshi, Principal, MET IOP, speaks exclusively with Pharma Industr...
India has emerged as a global pharmaceutical manufacturing hub, but transforming into an innovation-led ecosystem will require stronger policy reforms and deeper India-US collaboration...
Artificial Intelligence (AI) Centers of Excellence (CoEs), predictive manufacturing, and digital twins are reshaping pharma operations by enabling smarter, connected, and future-ready manufacturing ecosystems....
India’s pharma industry must shift from volume to value by investing in novel drug discovery, innovation, and research and development (R&D) to drive global leadership and sustainable growth....
By Darshana Daga
By Pharma Industrial India
Latest news in...
Premas Biotech announced the appointment of Saumen Chakraborty to the Premas Biotech Board of Directors. “I am delighte...
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development o...
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy